247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Supriya Lifescience Limited IPO (Supriya Lifescience IPO) Details

Supriya Lifescience Limited is an Pharmaceutical based company, located in Mumbai, Supriya Lifescience Limited IPO size was 700.00 Cr. and was issued at 274.00 per share. The share of Supriya Lifescience Limited were listed at 390.35 per share and are currently trading at 728.70 per share.

Type :
Sub Sector : Manufacturers And Suppliers Of Active Pharmaceuticals
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
460.12 Cr.

PAT :
131.92 Cr.

Pricing Report

Issue Price :
274.00

Listing Price :
390.35

Current Market Price :
728.70

Issue Price vs CMP :
454.7 (165.95%)

listing Price vs CMP :
338.35 (86.68%)

Performance Report (CAGR* wise)

CAGR : 37.54
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Supriya Lifescience

Company Information
Supriya Lifescience Limited is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs), with a focus on research and development. As of March 31, 2021, it has niche product offerings of 39 APIs, targeting diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively, of the API exports from India between Fiscal 2017 and 2020. It was also among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume (Source: CRISIL Report). The pharmaceutical business is organized into domestic and export sales based on the geographies in which the company operates. In
Show More
Object of Issue
  • Funding capital expenditure requirements of the company
  • Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company and
  • General corporate purposes

Supriya Lifescience MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Dec, 2021
IPO Size :
700.00 Cr.
IPO Subscription :
71.51 X     
PE Multiple :
17.80
Merchant Banker :
Axis Capital Limited
IPO Registrar:
Link Intime India Private Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in Mumbai

Abans Holdings Limited

  financial service arm of the well-diversified Abans group

  Mumbai



Advanced Enzyme Technologies Limited

  research and development manufacturing and marketing of healthcare products

  Mumbai


Peer Companies Of This Sector

FAQs

Supriya Lifescience operates in Pharmaceutical and Manufacturers And Suppliers Of Active Pharmaceuticals. The Issue is listed on MainBoard in Dec, 2021. Supriya Lifescience IPO size was 700.00 Cr. with Issue price of 274.00 .

Merchant Banker(s) of Supriya Lifescience IPO: Axis Capital Limited , ICICI Securities Limited

Supriya Lifescience IPO subscription was 71.51 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Supriya Lifescience IPO listed at a listing price of 390.35 against the offer price of 274.00.

The current market price of Supriya Lifescience is 728.70.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency